A New Automated Fourth-Generation HIV Screening Assay With Sensitive Antigen Detection Module and High Specificity

  • Bernard Weber
Part of the Methods in Molecular Biology™ book series (MIMB, volume 304)

Summary

New screening enzyme immunoassays, which permit the simultaneous detection of HIV antigens reduce the diagnostic window period between the time of immunodeficiency virus (HIV) infection and seroconversion. The VIDAS HIV DUO Ultra is an enzyme-linked fluorescent assay (ELFA) for the screening of HIV infection. It is performed with the fully automated VIDAS or mini-VIDAS instruments, which are so-called walk away systems. The detection limit is 3 pg of HIV-1 p24 Ag/mL serum. HIV antibody is detected with the same sensitivity as stand-alone third-generation antibody tests. The total incubation time is about 2 h. Results are calculated, interpreted, and printed by the VIDAS instrument. Usually, fourth-generation assays demand a special algorithm for the analysis of reactive samples. For the anti-HIV part of the assay, confirmation of reactivity should be done with an assay that lacks the p24-antigen detection module and when reactivity persists subsequently by immunoblot. For the p24-antigen part, confirmation of reactivity should be analyzed in an assay that lacks the anti-HIV detection part.

Key Words

Primary infection enzyme immunoassay (EIA) automated assay HIV screening 

References

  1. 1.
    Weber, B., Fall, E. M. B., Berger, A., and Doerr, H. W. (1998) Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J. Clin. Microbiol. 36, 2235–2239.PubMedGoogle Scholar
  2. 2.
    Gürtler, L., Mühlbacher, A., Michl, U., Hofmann, H., Paggi, G., Bossi, V., et al. (1998) Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. J. Virol. Meth. 75, 27–38.CrossRefGoogle Scholar
  3. 3.
    Weber, B., Berger, A., Rabenau, H., and Doerr, H. W. (2002) Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra. J. Clin. Microbiol. 40, 1420–1426.PubMedCrossRefGoogle Scholar
  4. 4.
    Weber, B., Gurtler, L., Thorstensson, R., Michl, U., Muhlbacher, A., Burgisser, P., et al. (2002) Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity. J. Clin. Microbiol. 40, 1938–1946.PubMedCrossRefGoogle Scholar
  5. 5.
    Weber, B., Thorstensson, R., Tanprasert, S., Schmitt, U., and Melchior, W. (2003) Reduction of the diagnostic window in three cases of human immunodeficiency — 1 subtype E primary infection with fourth-generation HIV screening assays. Vox Sanguinis 85, 73–79.PubMedCrossRefGoogle Scholar
  6. 6.
    Weber, B. (2003) HIV seroconversion: performance of combined antigen/antibody assays. AIDS 17, 931–945.PubMedCrossRefGoogle Scholar
  7. 7.
    Ly, T. D., Edlinger, C., and Vabret, A. (2000) Contribution of combined detection assays of p24 antigen and anti-human immunodeficiency virus (HIV) antibodies in diagnosis of primary HIV infection by routine testing. J. Clin. Microbiol. 38, 2459–2461.PubMedGoogle Scholar
  8. 8.
    Laboratory Bio Safety Manual, 2nd ed., 1993, WHO, Geneva, Switzerland.Google Scholar
  9. 9.
    Saville, R. D., Constantine, N. T., Cleghorn, F. R., Jack, N., Bartholomew, C., Edwards, J., et al. (2001) Fourth-generation enzyme linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody. J. Clin. Microbiol. 39, 2518–2524.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2005

Authors and Affiliations

  • Bernard Weber
    • 1
  1. 1.Department of Microbiology, Laboratoires RéunisCentre LangwiesJunglinsterLuxembourg

Personalised recommendations